medline.ch Onkologie Urologische Tumoren

	Efficacy, safety, and treatment feasibility of pembrolizumab plus lenvatinib in patients aged 75 years or older with advanced renal cell carcinoma: a Japanese multicenter retrospective study. Int J Clin Oncol Yamashita S, Yamasaki T, Ueda K, Tomida R, Toyoda S, Iwamoto H, Miyake M, Tomisaki I, Morizane S, Kohjimoto Y. PMID: 42377813 [PubMed - as supplied by publisher]
	Angiotensin Converting Enzyme (ACE) insertion/deletion (rs1799752) gene polymorphism and bladder cancer aggressiveness in Egyptian patients: A pilot case-control study. Mol Biol Rep Atia N, Osman Y, Abdel-Aziz AF, Refaat S, Khalil MR, Refaat M. PMID: 42377753 [PubMed - indexed for MEDLINE]
	4D flow MRI for the evaluation of venous anatomy and flow in renal cell carcinoma with venous tumor thrombus: a pictorial essay. Abdom Radiol (NY) Wentland AL, García-Rodríguez S, Roadman DF, Wieben O, Ansari N, Shapiro DD, Abel EJ. PMID: 42377543 [PubMed - as supplied by publisher]
	(18)F-Fluciclovine or (68)Ga-PSMA-11 PET/CT-guided Salvage Radiotherapy Changes in Postprostatectomy Biochemical Recurrence: Secondary Analysis of the EMPIRE-2 Trial. Radiology Abiodun-Ojo OA, Jani AB, Goyal S, Lawal IO, Halkar RK, Dhere V, Shelton JW, Patel PR, Schreibmann E, Hershatter B, Patel SA, Hanasoge S, Sebastian NT, Schuster DM. PMID: 42377125 [PubMed - indexed for MEDLINE]
	Predictive biomarkers of response in metastatic prostate cancer: paving the way for a new era of precision medicine. Expert Rev Anticancer Ther Mercinelli C, Di Costanzo F, Oing C, Guandalini G, Maiorano BA, Sammarco E, Salfi A, Serafin D, Tateo V, Cigliola A, Piacentini M, Pastorino GL, Galli L, Conteduca V, Formisano L, Rescigno P, Necchi A. PMID: 42376796 [PubMed - as supplied by publisher]
	Common Bile Duct Diameter in Bladder Urothelial Carcinoma: A Case-Control Study. Cancer Manag Res Dadkhah A, Zolfaghari M, Bagheri SM, Soltani S, Fooladi Z, Emami M. PMID: 42376600 [PubMed]
	State of the nation: Understanding the current NHS treatment pathway to identify opportunities to advance future care of patients with high-risk non-muscle invasive bladder cancer in the UK (SPAN-UK). BJUI Compass Aning J, Catto JWF, Martin R, Chatterton K, Mariappan P, Ottley E, Hickey J, McCormack S, Gill S, Szabados B. PMID: 42375995 [PubMed]
	Prostate Cancer: Etiology, Diagnosis, and Treatment. Serican J Med Li C, Li Z, Liu X. PMID: 42375929 [PubMed]
	Does body mass index affect the proper pre-operative grade and stage assessment in patients with prostate cancer undergoing radical prostatectomy? Cent European J Urol Drewa J, Adamowicz J, Juszczak K. PMID: 42375717 [PubMed]
	[Descriptive analytical study of patient survival with vertebral metastases in a rheumatological setting in Togo]. Pan Afr Med J Oniankitan S, Diallo ML, Fianyo E, Ataké AE, Diallo MB, Komi TC, Koffi-Tessio VES, Kakpovi K, Houzou P, Oniankitan O. PMID: 42375555 [PubMed - indexed for MEDLINE]
	Case Report: Immune checkpoint inhibitor-associated myocarditis, myositis, and myasthenia gravis overlap syndrome with flow cytometric phenotyping before and after treatment in a patient with urothelial carcinoma. Front Immunol Gambina K, Tymm C, Paiola M, Tanji K, Zech J, Winchester R, Mor A, Gartshteyn Y. PMID: 42375375 [PubMed - indexed for MEDLINE]
	What should the urologist know on the management of kidney cancer in patients with Von Hippel-Lindau syndrome? Recommendations of the European Association of Urology (EAU) Young Academic Urologists (YAU) Renal Cancer Working Group. World J Urol Erdem S, Amparore D, Re C, Verep S, Capitanio U, Larcher A, Roussel E, Klatte T, Bertolo R, Muselaers S, Pavan N, Kara O, Ingels A, Pecoraro A, Marchioni M, Pandolfo SD, Diana P, Carbonara U, Mollica V, Warren H, Borregales L, Marandino L, Sharma G, Caliò A, Wu Z, Lovati LA, Ciccarese C, Margue G, Francolini G, Flippot R, Leung DK, Mjaess G, Rosiello G, Mir MC, Palumbo C, Campi R, EAU-YAU Renal Cancer Working Group. PMID: 42373875 [PubMed - indexed for MEDLINE]
	Circulating metabolite biomarkers associated with prostate cancer risk in Black Americans: findings from the Southern Community Cohort Study. Br J Cancer Yoon HS, Shu XO, Wu J, Sanderson M, Wang X, Wen W, Courtney R, Yang JJ, Blot WJ, Zheng W, Cai Q. PMID: 42373845 [PubMed - as supplied by publisher]
	Reply to Yue Chang's Letter to the Editor re: Contieri R, Paciotti M, Uleri A, et al. Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe trial. Eur Urol Oncol 2026;9:404-12. Eur Urol Oncol Contieri R, Hurle R. PMID: 42373419 [PubMed - as supplied by publisher]
	Re: Hormone Therapy Use and Duration with Postoperative Radiotherapy for Recurrent Prostate Cancer: an Individual Patient Data Meta-analysis. Eur Urol Viti A, Scuderi S, Cucchiara V, Gandaglia G, Briganti A, Montorsi F. PMID: 42373361 [PubMed - as supplied by publisher]
	Re: Nguyen DD, Tadayon Najafabadi B, Lin L, et al. Effect of Prostate Cancer Screening with Prostate-specific Antigen Testing on Long-term Prostate Cancer-specific Mortality: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2026.04.005. Eur Urol Takahashi T. PMID: 42373360 [PubMed - as supplied by publisher]
	Bayesian Analysis to Refine East Asian Subgroup Estimates in the CLEAR Trial (Lenvatinib Plus Pembrolizumab vs. Sunitinib) for Advanced Renal Cell Carcinoma. Anticancer Res Fujiwara M, Yoshida S, Yajima S, Sato H, Hirakawa A, Fukushima H, Arita Y, Tanaka H, Yokoyama M, Masuda H, Fujii Y. PMID: 42373289 [PubMed - indexed for MEDLINE]
	Urinary Lipid Profiling for Biomarker Discovery in Clear Cell Renal Cell Carcinoma. Anticancer Res Ishikawa G, Tamura K, Watanabe K, Matsushita Y, Watanabe H, Motoyama D, Inamoto T. PMID: 42373281 [PubMed - indexed for MEDLINE]
	Real-world Comparison of Avelumab Maintenance and Enfortumab Vedotin Plus Pembrolizumab in Metastatic Urothelial Carcinoma. Anticancer Res Yen TH, Wang SS, Chen CS, Chen CC, Lin CY, Hung SC, Lai GS, Li JR, Yang CK, Lin YC. PMID: 42373274 [PubMed - indexed for MEDLINE]
	Dual Bipolar Strategy and Postoperative Drain Output in Robot-assisted Radical Nephrectomy. Anticancer Res Miyazaki T, Yamazaki F, Fukuhara Y, Iwata A, Sako R, Miyahara T, Noda K, Yokoyama R, Yamashita S, Fujikawa A, Aso S, Aoyagi C, Tachibana M, Tominaga K, Okabe YU, Gunge N, Haga N. PMID: 42373272 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 179595

Seite 1 von 8980

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung